Stem Cell Therapy Restores Insulin Production in Type 1 Diabetes Study

A new study published in the New England Journal of Medicine examined stem cell therapy as a potential way to restore insulin production in people with Type 1 diabetes. Of the 14 patients enrolled, 12 completed the trial. Among those 12, insulin injections were reduced or eliminated entirely in all participants. Most impressively, 83% no longer required insulin therapy 12 months after treatment began.

The research focused on restoring the function of beta cells—the insulin-producing cells located in clusters in the pancreas called the islets of Langerhans. In Type 1 diabetes, these cells are damaged or destroyed, forcing people to rely on insulin injections to control blood sugar.

This study involved significant risks. Two of the 14 patients died during the trial. One death was caused by cryptococcal meningitis, an infection, and the other resulted from a pre-existing dementia condition. These outcomes underscore that stem cell therapy, while experimental, carries real dangers and requires careful monitoring.

Researchers emphasize an important distinction: restoring some pancreatic function is valuable, even if it doesn't completely eliminate the need for insulin. As the study authors note, 'eliminating the need for exogenous insulin is desirable,' but the clinical benefits extend beyond that single outcome. Partial restoration of insulin production can meaningfully improve blood sugar control and reduce insulin dependency.

Dr. Rémi Rabasa-Lhoret, an expert on Type 1 diabetes at the Montreal Clinical Research Institute, called this work a step forward, though he acknowledged the study remains 'far from perfect.'

Experts in the diabetes community view this research as groundbreaking early progress. However, this is still experimental work. Much more research is needed to understand whether stem cell therapy can be safely and reliably applied to larger numbers of patients, and to determine which patients might benefit most from this approach.

Origin: montreal.citynews.ca (News report). Evidence: News report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.